Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Non Operating Income (2009 - 2026)

Updated

Analysis

Savara (SVRA) Non Operating Income (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - 553,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 553,000.00
Jun 30, 2026 737,000.00
Mar 31, 2026 1.71 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 694,000.00
Jun 30, 2025 1.04 Mn
Mar 31, 2025 1.80 Mn
Dec 31, 2024 2.13 Mn
Sep 30, 2024 2.11 Mn
Jun 30, 2024 947,000.00
Mar 31, 2024 2.13 Mn
Dec 31, 2023 1.53 Mn
Sep 30, 2023 1.45 Mn
Jun 30, 2023 778,000.00
Mar 31, 2023 1.56 Mn
Dec 31, 2022 575,000.00
Sep 30, 2022 149,000.00
Jun 30, 2022 219,000.00
Mar 31, 2022 -254,000.00
Dec 31, 2021 -671,000.00
API Access

Savara Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=SVRA&period=max&api_key=YOUR_API_KEY